Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Topical Intra-Oral Ketoprofen for Migraine Prevention [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating topical intra-oral ketoprofen for migraine prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoprofen (Ketoprofen)

Snippet

Sponsor: Behar, Caren, M.D. | Conditions: Migraine | Phase 3 | Status: COMPLETED